Chimeric Antigen Receptor T-cell,CAR-T therapy , Cancer treatment in India, Tata Hospital Mumbai,

Cancer: First CAR-T cell therapy conducted at ACTREC, Tata Hospital

New Delhi, June 11, 2021: The Chimeric Antigen Receptor T-cell (CAR-T) therapy has emerged as a breakthrough in cancer treatment. Clinical trials conducted globally have shown promising results in end stage patients, especially in patients suffering from Acute Lymphocytic Leukemia. Though this technology has a remarkable therapeutic potential for cancer patients, at present this technology is […]

ASPAGNIITM may revolutionise cancer treatment

New Delhi, June 5, 2021: To successfully implement innovation newer modalities for cancer treatment, researchers at the New Delhi-based National Institute of Immunology (NII), an Autonomous Institute of Department of Biotechnology (DBT), and clinicians at Cancer Institute, Adyar, Chennai have been working together to translate new scientific discoveries into improved care for cancer patients. Over […]